Skip to NavigationSkip to content

US Senate pass bipartisan bill to tackle opioid crisis

Published on 18/09/18 at 11:01am

The US Senate have passed a bipartisan bill aimed at combatting the opioid crisis.

The bill, which was passed with a 99-1 vote, includes more than 70 provisions aimed at tackling the opioid crisis.

Senator Mike Lee, a libertarian leaning Republican representative for Utah, was the only Senator to oppose the bill.

The bill sets out tochannel money towards research into non-addictive painkillers while also introducing measures to prevent synthetic opioids from being imported into the United States illegally.

Senate Health Committee Chairman, Lamar Alexander (Republican,Tennesse) commented: “This legislation represents the work of over 70 senators, five committees, and countless staff who have worked together to help put an end to the opioid epidemic ravaging virtually every American community."

"The proposed bill includes the STOP Act to help stop illegal drugs at the border, including stopping the shipment of synthetic opioids. It allows the FDA to require prescription opioids to be packaged in set amounts like a 3 or 7 day supply of blister packs, and spurs the development of a new non-addictive painkiller."

"The House has already passed its version of the act, and there is a bipartisan urgency to work with our House colleagues to get the legislation to the President’s desk.”

Louis Goss

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches